Application 075646
- Type
- ANDA
- Sponsor
- YAOPHARMA CO LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | TABLET;ORAL | EQ 1MG BASE | No | No |
| 002 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | TABLET;ORAL | EQ 2MG BASE | No | No |
| 003 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | TABLET;ORAL | EQ 4MG BASE | No | No |
| 004 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | TABLET;ORAL | EQ 8MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075646-001 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2000-10-18 | ||
| A075646-002 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2000-10-18 | ||
| A075646-003 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2000-10-18 | ||
| A075646-004 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2000-10-18 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075646-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2000-10-18 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075646-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2000-10-18 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075646-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2000-10-18 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075646-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2000-10-18 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075646-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2000-10-18 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075646-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2000-10-18 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075646-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2000-10-18 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075646-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2000-10-18 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A075646-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2000-10-18 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A075646-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2000-10-18 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A075646-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2000-10-18 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A075646-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2000-10-18 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075646-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2000-10-18 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075646-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2000-10-18 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075646-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2000-10-18 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075646-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2000-10-18 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075646-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2000-10-18 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075646-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2000-10-18 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075646-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2000-10-18 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075646-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2000-10-18 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075646-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2000-10-18 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075646-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2000-10-18 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075646-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2000-10-18 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075646-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2000-10-18 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A075646-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2000-10-18 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A075646-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2000-10-18 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A075646-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2000-10-18 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A075646-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2000-10-18 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A075646-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2000-10-18 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A075646-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2000-10-18 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A075646-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2000-10-18 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A075646-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2000-10-18 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A075646-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2000-10-18 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A075646-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2000-10-18 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A075646-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2000-10-18 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A075646-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2000-10-18 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A075646-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | 2000-10-18 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A075646-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | 2000-10-18 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A075646-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | 2000-10-18 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A075646-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | 2000-10-18 | 4b0b4de00fa7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxazosin mesylate | DOXAZOSIN MESYLATE | Chartwell RX, LLC | a7f589b0-eebb-48cb-912f-a4bd956e4dcb | 2023-06-09 | Warnings, Adverse reactions | 075646 ANDA075646 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 30973 | ORIG | 2000-10-18 |